mega888 apk FDA approves new weight loss drug Zepbound [3sQqhGs2Fr6]

The FDA approved a new drug for obesity, Zepbound, made by Eli Lilly, which is potentially more effective at losing weight than any other drug







FDA approves new weight loss drug Zepbound [3sQqhGs2Fr6]

FDA approves new weight loss drug Zepbound [3sQqhGs2Fr6]

| 1h 28m 28s | Video has closed captioning.

The FDA approved a new drug for obesity, Zepbound, made by Eli Lilly, which is potentially more effective at losing weight than any other drug on the market. The medication is already being sold as diabetes drug Mounjaro. NBC News’ Stephanie Gosk has more details.

» Subscribe to NBC News: http://nbcnews.to/SubscribeToNBC
» Watch more NBC video: http://bit.ly/MoreNBCNews

NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original journalism and segments from your favorite NBC News Shows.

Connect with NBC News Online!
NBC News App: https://smart.link/5d0cd9df61b80
Breaking News Alerts: https://link.nbcnews.com/join/5cj/breaking-news-signup?cid=sm_npd_nn_yt_bn-clip_190621
Visit NBCNews.Com: http://nbcnews.to/ReadNBC
Find NBC News on Facebook: http://nbcnews.to/LikeNBC
Follow NBC News on Twitter: http://nbcnews.to/FollowNBC
Get more of NBC News delivered to your inbox: nbcnews.com/newsletters

#FDA #WeightLoss #Medication #Lose Weight in Your Sleep 8 Ways # The Best Weight Loss Diet Plan for Women # 500 Calories in Different Foods weight loss weightloss calories nutrition diet

Aired: January 19, 2025

Rating: TV-14

Buy Now:

Problems Playing Video? | Closed Captioning

Learn About Midwifery Today

Blog

Learn About Midwifery Today

Read the Modern Day Midwives Blog and learn more about our bloggers, all experienced midwives.

Read now